Royalty Pharma Plc (RPRX)

Oct 01, 2026

Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy? - theglobeandmail.com

Oct 01, 2026

Oct 01, 2026

Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy? - The Motley Fool

Oct 01, 2026

Oct 01, 2026

Form 4 Royalty Pharma Plc For: 1 October - Investing.com India

Oct 01, 2026

Sep 30, 2026

Form 4 Royalty Pharma Plc For: 30 September By Investing.com - Investing.com Nigeria

Sep 30, 2026

Sep 30, 2026

Royalty Pharma EVP Marshall Urist sells $238,812 in shares - Investing.com

Sep 30, 2026

Sep 30, 2026

Royalty Pharma (NASDAQ:RPRX) EVP Marshall Urist Sells 4,126 Shares of Stock - MarketBeat

Sep 30, 2026

Sep 30, 2026

A director acquires 642 shares in lieu of a $37,500 retainer at Royalty Pharma (RPRX). - Stock Titan

Sep 30, 2026

Sep 30, 2026

4,126 shares sold under a trading plan by Royalty Pharma (RPRX) EVP Marshall Urist. - Stock Titan

Sep 30, 2026

Sep 29, 2026

If You Invested $100 In Royalty Pharma Stock 10 Years Ago, You Would Have This Much Today - Benzinga

Sep 29, 2026

Sep 29, 2026

Operating cash flow per share of Royalty Pharma Plc Class A – HAN:RPD - TradingView

Sep 29, 2026

Sep 29, 2026

RPD Forecast — Price Target — Prediction for 2027 - TradingView

Sep 29, 2026

Sep 29, 2026

Form 144 Royalty Pharma plc For: 29 September By Investing.com - Investing.com Nigeria

Sep 29, 2026

Sep 29, 2026

RPHC5824522 Bond Profile: Coupon and Redemption - TradingView

Sep 29, 2026

Sep 28, 2026

Royalty Pharma officer proposes $239K share sale | RPRX SEC FilingForm 144 - Stock Titan

Sep 28, 2026

Sep 27, 2026

Form 144 Royalty Pharma PLC For: 27 September By Investing.com - Investing.com Australia

Sep 27, 2026

Sep 26, 2026

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar - Eastern Progress

Sep 26, 2026

Sep 26, 2026

Royalty Pharma (NASDAQ:RPRX) Rating Lowered to Buy at Wall Street Zen - MarketBeat

Sep 26, 2026

Sep 25, 2026

Form 4 Royalty Pharma Plc For: 25 September By Investing.com - Investing.com India

Sep 25, 2026

Sep 25, 2026

Royalty Pharma EVP Christopher Hite sells $5.85m in shares By Investing.com - Investing.com Canada

Sep 25, 2026

Sep 25, 2026

Royalty Pharma EVP Christopher Hite sells $5.85m in shares - Investing.com

Sep 25, 2026

Sep 25, 2026

Royalty Pharma plc (RPRX) stock price, news, quote and history - Yahoo Finance Singapore

Sep 25, 2026

Sep 25, 2026

Royalty Pharma Eyes AI, China Growth While Navigating Biopharma Policy Shifts - MarketBeat

Sep 25, 2026

Sep 24, 2026

Is Buying Royalty Pharma Stock a Safer Way to Bet on Revolution Medicines? - The Motley Fool

Sep 24, 2026

Sep 24, 2026

Insider Selling: Royalty Pharma (NASDAQ:RPRX) EVP Sells $5,853,000.00 in Stock - MarketBeat

Sep 24, 2026

Sep 24, 2026

A prearranged plan governed SCH Investment Partners’ sale of 100,000 Royalty Pharma (RPRX) shares. - Stock Titan

Sep 24, 2026

Sep 24, 2026

Royalty Pharma plc (RPRX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 24, 2026

Sep 24, 2026

RPHC5237354 Bond Profile: Coupon and Redemption - TradingView

Sep 24, 2026

Sep 23, 2026

Royalty Pharma PLC (RPD) Q4 2022 Earnings ReportResults, Call & Slides - TipRanks

Sep 23, 2026

Sep 23, 2026

Royalty Pharma PLC (RPD) Q2 2023 Earnings ReportResults, Call & Slides - TipRanks

Sep 23, 2026

Sep 23, 2026

Royalty Pharma PLC (RPD) Q2 2026 Earnings ReportResults, Call & Slides - TipRanks

Sep 23, 2026

Sep 23, 2026

Royalty Pharma PLC (RPD) Q3 2023 Earnings ReportResults, Call & Slides - TipRanks

Sep 23, 2026

Sep 23, 2026

Royalty Pharma PLC (RPD) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks

Sep 23, 2026

Sep 23, 2026

Royalty Pharma PLC (RPD) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks

Sep 23, 2026

Sep 23, 2026

Royalty Pharma PLC (RPD) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks

Sep 23, 2026

Sep 23, 2026

Royalty Pharma PLC (RPD) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks

Sep 23, 2026

Sep 23, 2026

Royalty Pharma PLC (RPD) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks

Sep 23, 2026

Sep 23, 2026

Royalty Pharma PLC (RPD) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks

Sep 23, 2026

Sep 23, 2026

RPRX: Strategic AI, scalable deal models, and China expansion drive robust, diversified growth - TradingView

Sep 23, 2026

Sep 23, 2026

Royalty Pharma PLC (RPD) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks

Sep 23, 2026

Sep 23, 2026

Royalty Pharma at Bank of America Global Healthcare Conference: growth even with policy risks - Investing.com Nigeria

Sep 23, 2026

Sep 23, 2026

Royalty Pharma (RPRX) Stock Looks Richly Priced After Its 136% Run - Yahoo Finance

Sep 23, 2026

Sep 23, 2026

Price-Driven Insight from (RPRX) for Rule-Based Strategy - Stock Traders Daily

Sep 23, 2026

Sep 23, 2026

Royalty Pharma (RPRX) Could Be 10% Undervalued As Conference Spotlight Returns - Yahoo Finance

Sep 23, 2026

Sep 23, 2026

Andra AP fonden Lowers Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat

Sep 23, 2026

Sep 22, 2026

Royalty Pharma PLC (RPD) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks

Sep 22, 2026

Sep 22, 2026

Royalty Pharma (RPRX) holder plans new sale after selling 350,000 shares - Stock Titan

Sep 22, 2026